No phaseActive, not recruiting

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans (NR-VET)

Sponsor
VA Office of Research and Development (US federal)
Enrolment
74 enrolled
Conditions
Sarcopenia; Nicotinamide Adenine Dinucleotide Concentration; Muscle Quality and NAD+ Content
Interventions
Nicotinamide Riboside; Placebo
Ages
older adults
Registry
NCT04691986

From the registry

Frailty is an age-associated clinical condition of poor physiological reserve that increases risks for falls, hospitalization and mortality. Nicotinamide adenine dinucleotide (NAD) is a critical co-factor needed for many cellular processes. The natural levels of NAD decline aging and this has been linked to physical performance decline in animals. Human trials have demonstrated that nicotinamide riboside (NR), a form of vitamin B3, is safe and effectively increases NAD+ levels. In animal studies, NR improves treadmill performance and muscle quality. Here the investigators propose a double-blind randomized control trial to assess the benefits of NR supplementation on human muscle function and physiology. The investigators anticipate the research findings will support the use of this nutritional supplement to improve the health of Veterans during aging.

Primary outcomes

  • Sub-maximal oxygen uptake test (VO2max)
  • Muscle strength
  • Gait speed
Full record on ClinicalTrials.gov